Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Bicycle Therapeutics Plc ADR (NASDAQ: BCYC) closed at $22.56 down -0.66% from its previous closing price of $22.71. In other words, the price has decreased by -$0.66 from its previous closing price. On the day, 0.44 million shares were traded. BCYC stock price reached its highest trading level at $22.91 during the session, while it also had its lowest trading level at $21.846.
Ratios:
For a deeper understanding of Bicycle Therapeutics Plc ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.77 and its Current Ratio is at 14.77. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, RBC Capital Mkts on September 06, 2024, initiated with a Outperform rating and assigned the stock a target price of $35.
On August 07, 2024, B. Riley Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $33 to $28.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 03 ’24 when Hannay Michael Charles Ferguso sold 246 shares for $19.64 per share. The transaction valued at 4,831 led to the insider holds 22,645 shares of the business.
Skynner Michael sold 967 shares of BCYC for $18,992 on Jul 03 ’24. The CHIEF TECHNOLOGY OFFICER now owns 93,917 shares after completing the transaction at $19.64 per share. On Jul 03 ’24, another insider, Thompson Travis Alvin, who serves as the CHIEF ACCOUNTING OFFICER of the company, sold 148 shares for $19.64 each. As a result, the insider received 2,907 and left with 23,075 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCYC now has a Market Capitalization of 1556493440 and an Enterprise Value of 637865408. For the stock, the TTM Price-to-Sale (P/S) ratio is 39.28 while its Price-to-Book (P/B) ratio in mrq is 1.78. Its current Enterprise Value per Revenue stands at 16.118 whereas that against EBITDA is -3.609.
Stock Price History:
Over the past 52 weeks, BCYC has reached a high of $28.20, while it has fallen to a 52-week low of $12.54. The 50-Day Moving Average of the stock is -3.97%, while the 200-Day Moving Average is calculated to be 2.19%.
Shares Statistics:
For the past three months, BCYC has traded an average of 302.04K shares per day and 405150 over the past ten days. A total of 68.94M shares are outstanding, with a floating share count of 65.84M. Insiders hold about 4.51% of the company’s shares, while institutions hold 54.95% stake in the company. Shares short for BCYC as of 1726185600 were 2361093 with a Short Ratio of 7.82, compared to 1723680000 on 2204433. Therefore, it implies a Short% of Shares Outstanding of 2361093 and a Short% of Float of 5.3600002.
